Cargando…
Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic
OBJECTIVE: To assess differences in the prevalence of anxiety/depression symptoms among cancer patients before (2019) and during the COVID‐19 pandemic (2020); and the associations between anxiety/depression and sociodemographic and health behavior factors among cancer patients before and during the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762178/ https://www.ncbi.nlm.nih.gov/pubmed/36029183 http://dx.doi.org/10.1002/pon.6026 |
_version_ | 1784852815881961472 |
---|---|
author | Adzrago, David Sulley, Saanie Tagoe, Ishmael Ormiston, Cameron K. Odame, Emmanuel A. Mamudu, Lohuwa Williams, Faustine |
author_facet | Adzrago, David Sulley, Saanie Tagoe, Ishmael Ormiston, Cameron K. Odame, Emmanuel A. Mamudu, Lohuwa Williams, Faustine |
author_sort | Adzrago, David |
collection | PubMed |
description | OBJECTIVE: To assess differences in the prevalence of anxiety/depression symptoms among cancer patients before (2019) and during the COVID‐19 pandemic (2020); and the associations between anxiety/depression and sociodemographic and health behavior factors among cancer patients before and during the pandemic. METHODS: We analyzed data from the 2019 (n = 856) and 2020 (n = 626) Health Information National Trends Survey, a nationally representative survey of United States adults aged ≥18 years. Only adults with a cancer diagnosis were used in the analyses. Anxiety/depression was assessed using the Patient Health Questionnaire‐4 (low/none [0–2], mild [3–5], moderate [6–8], and severe [9–12]) and dichotomized as low/none and current anxiety/depression (mild/moderate/severe). Multivariate analysis was performed. RESULTS: The prevalence of anxiety/depression symptoms among cancer patients was 32.7% before the COVID‐19 pandemic and 31.1% during the pandemic. The odds of anxiety/depression among patients with fair/poor health status was higher during the pandemic relative to before (before: odds ratio [OR] = 1.85 vs. during: OR = 3.89). Participants aged 50–64 years (before: OR = 0.29, 95% confidence interval [95% CI] = 0.11–0.76; during: OR = 0.33, 95% CI = 0.11–0.97) and ≥65 years (before: OR = 0.13, 95% CI = 0.05–0.34; during: OR = 0.18, 95% CI = 0.07–0.47) had lower odds of anxiety/depression before and during the pandemic compared to those aged 35–49 years. Hispanics/Latinos had higher odds of anxiety/depression (OR = 2.70, 95% CI = 1.11–6.57) before the pandemic and lower odds of anxiety/depression during the pandemic (OR = 0.2, 95% CI = 0.05–1.01) compared to non‐Hispanic Whites. Those who completed high school (before: OR = 0.08, 95% CI = 0.01–0.42), some college (before: OR = 0.10, 95% CI = 0.02–0.42), ≥college degree had lower odds of anxiety/depression symptoms (before: OR = 0.05, 95% CI = 0.01–0.26; during: OR = 0.06, 95% CI = 0.01–0.61) compared to those with less than a high school education. CONCLUSION: Our results suggest the need to increase the provision of mental health services to cancer patients at high risk of developing anxiety/depression symptoms, particularly during public health emergencies, to alleviate further health burdens. |
format | Online Article Text |
id | pubmed-9762178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97621782022-12-19 Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic Adzrago, David Sulley, Saanie Tagoe, Ishmael Ormiston, Cameron K. Odame, Emmanuel A. Mamudu, Lohuwa Williams, Faustine Psychooncology Original Articles OBJECTIVE: To assess differences in the prevalence of anxiety/depression symptoms among cancer patients before (2019) and during the COVID‐19 pandemic (2020); and the associations between anxiety/depression and sociodemographic and health behavior factors among cancer patients before and during the pandemic. METHODS: We analyzed data from the 2019 (n = 856) and 2020 (n = 626) Health Information National Trends Survey, a nationally representative survey of United States adults aged ≥18 years. Only adults with a cancer diagnosis were used in the analyses. Anxiety/depression was assessed using the Patient Health Questionnaire‐4 (low/none [0–2], mild [3–5], moderate [6–8], and severe [9–12]) and dichotomized as low/none and current anxiety/depression (mild/moderate/severe). Multivariate analysis was performed. RESULTS: The prevalence of anxiety/depression symptoms among cancer patients was 32.7% before the COVID‐19 pandemic and 31.1% during the pandemic. The odds of anxiety/depression among patients with fair/poor health status was higher during the pandemic relative to before (before: odds ratio [OR] = 1.85 vs. during: OR = 3.89). Participants aged 50–64 years (before: OR = 0.29, 95% confidence interval [95% CI] = 0.11–0.76; during: OR = 0.33, 95% CI = 0.11–0.97) and ≥65 years (before: OR = 0.13, 95% CI = 0.05–0.34; during: OR = 0.18, 95% CI = 0.07–0.47) had lower odds of anxiety/depression before and during the pandemic compared to those aged 35–49 years. Hispanics/Latinos had higher odds of anxiety/depression (OR = 2.70, 95% CI = 1.11–6.57) before the pandemic and lower odds of anxiety/depression during the pandemic (OR = 0.2, 95% CI = 0.05–1.01) compared to non‐Hispanic Whites. Those who completed high school (before: OR = 0.08, 95% CI = 0.01–0.42), some college (before: OR = 0.10, 95% CI = 0.02–0.42), ≥college degree had lower odds of anxiety/depression symptoms (before: OR = 0.05, 95% CI = 0.01–0.26; during: OR = 0.06, 95% CI = 0.01–0.61) compared to those with less than a high school education. CONCLUSION: Our results suggest the need to increase the provision of mental health services to cancer patients at high risk of developing anxiety/depression symptoms, particularly during public health emergencies, to alleviate further health burdens. John Wiley and Sons Inc. 2022-09-14 2022-10 /pmc/articles/PMC9762178/ /pubmed/36029183 http://dx.doi.org/10.1002/pon.6026 Text en © 2022 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Adzrago, David Sulley, Saanie Tagoe, Ishmael Ormiston, Cameron K. Odame, Emmanuel A. Mamudu, Lohuwa Williams, Faustine Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic |
title | Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic |
title_full | Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic |
title_fullStr | Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic |
title_full_unstemmed | Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic |
title_short | Assessment of anxiety/depression among cancer patients before and during the COVID‐19 pandemic |
title_sort | assessment of anxiety/depression among cancer patients before and during the covid‐19 pandemic |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762178/ https://www.ncbi.nlm.nih.gov/pubmed/36029183 http://dx.doi.org/10.1002/pon.6026 |
work_keys_str_mv | AT adzragodavid assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic AT sulleysaanie assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic AT tagoeishmael assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic AT ormistoncameronk assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic AT odameemmanuela assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic AT mamudulohuwa assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic AT williamsfaustine assessmentofanxietydepressionamongcancerpatientsbeforeandduringthecovid19pandemic |